{
    "nctId": "NCT01726322",
    "briefTitle": "Ovarian Reserve in Premenopausal Breast Cancer",
    "officialTitle": "A Study to Determine Alteration of Hormone Levels in Premenopausal Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Premenopausal Breast Cancer, Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 216,
    "primaryOutcomeMeasure": "Alteration of hormone levels in premenopausal patients receiving adjuvant or neo-adjuvant chemotherapy for breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Documented histological diagnosis of invasive breast cancer\n2. Patient due to be treated with chemotherapy (neoadjuvant or adjuvant)\\*\n3. Female patients aged between 18 and 50 years\n4. Premenopausal status as defined by a hormone profile within the pre-menopausal range as defined by local lab\n\n   OR The patient's last menstrual period had to be within the last 180 days\n\n   OR An IUD is used for contraception.\n5. Ability to provide written informed consent\n\n   * Patients treated with GNRH agonist or adjuvant Herceptin or participating in other clinical trials are also eligible\n\nExclusion Criteria:\n\n1. Patients with hypothalamic/pituitary disorder\n2. History of ovarian tumour\n3. Current pregnancy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}